Nanosized Drug Delivery Systems to Fight Tuberculosis

Tuberculosis (TB) is currently the second deadliest infectious disease. Existing antitubercular therapies are long, complex, and have severe side effects that result in low patient compliance. In this context, nanosized drug delivery systems (DDSs) have the potential to optimize the treatment’s effi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bourguignon, Tom, Godinez-Leon, Jesus Alfredo, Gref, Ruxandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964171/
https://www.ncbi.nlm.nih.gov/pubmed/36839715
http://dx.doi.org/10.3390/pharmaceutics15020393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964171/
https://www.ncbi.nlm.nih.gov/pubmed/36839715
http://dx.doi.org/10.3390/pharmaceutics15020393

Ejemplares similares